ML is poised to become faster and more accessible by 2026. Simply having the support of GenAI already gives it an advantage over other AI-based solutions.

ML Bio Solutions’ sponsored lead-in study is enrolling patients with LGMD2i across twelve sites in the U.S. and internationally, in collaboration with the LGMD-GRASP consortium SAN FRANCISCO, June 11, ...

SANTA CLARA, Calif., Oct. 01, 2025 (GLOBE NEWSWIRE) -- PDF Solutions, Inc. (Nasdaq: PDFS), today announced the upcoming release of the next generation of its Exensio AI/ML (i.e. ModelOps) solution: ...

PALM HARBOR, Fla., June 27, 2024 /PRNewswire/ -- Geographic Solutions, a leading provider of workforce development software for the government and the public sector, is proud to announce its VOS ...

Semiconductor designs continue to push the envelope of performance, functionality, and efficiency while their application scope expands in high-performance computing, automotive solutions, and IoT ...

AI/ML is increasingly pervasive across all industries driven by a massive wave of digitization. Data, the raw material of AI/ML and Deep Learning algorithms, is available in enormous quantities from ...

Ambarella AMBA recently announced a collaboration with Amazon’s AMZN cloud computing arm, AWS, enabling customers to use Amazon SageMaker Neo cloud service to run ML models on devices based on ...

An enterprise (which shall remain nameless) invested heavily in the purchase a machine learning solution to optimize one of its key processes. It worked with a vendor of “best in class” machine ...

ML Bio Solutions has initiated a Phase 1 clinical trial of BBP-418 in healthy volunteers ML Bio Solutions’ sponsored lead-in study is enrolling patients with LGMD2i across twelve sites in the U.S. and ...